4D Molecular Therapeutics
Powering the Future of Genetic Medicines
209 employees · est. 2013 · Emeryville, United States
Oxurion NV is the older company (2013 vs 1991); 4D Molecular Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | 4D Molecular Therapeutics | Oxurion NV |
|---|---|---|
| Founded | ||
| Founded | 2013 | 1991 older |
| Headquarters | ||
| Headquarters | Emeryville, United States | Leuven, Belgium |
| Employees | ||
| Employees | 209 larger | 33 |
| Industry | ||
| Industry | Biotechnology | Biotechnology, Life Sciences |
| Funding Stage | ||
| Funding Stage | Post Ipo Equity | Post Ipo Debt |
| Total Funding | ||
| Total Funding | $595.00M | $143.25M |
| Funding Rounds | ||
| Funding Rounds | 6 | 12 |
| Services | ||
| Services | Development of genetic medicines, Innovative vector platform, Clinical trial execution, Partnerships with patient organizations | Not tracked yet |
| Target Customers | ||
| Target Customers | Patients with retinal diseases, Patients with pulmonary diseases, Healthcare providers, Research organizations | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Genetic Medicines, Gene Therapy, Adeno-Associated Virus, Retinal Vascular Diseases, Ophthalmology, Wet Age-Related Macular Degeneration, Diabetic Macular Edema, Cystic Fibrosis, Clinical Trials, Medical Innovation, Therapeutic Products, Anti-VEGF Therapy, Transgene Delivery, Intravitreal Injection | Biopharmaceutical Company, Ophthalmic Therapies, Retinal Disorders, Diabetic Macular Edema, DME Treatment, Plasma Kallikrein Inhibitor, Standard Of Care, Vision Preservation, Vascular Disorders, Anti-VEGF Therapy, Biopharmaceutical Research, Innovative Therapies, Drug Development, Medical Innovation, Clinical Trials |
| Website | ||
| Website | 4dmoleculartherapeutics.com | oxurion.com |
About 4D Molecular Therapeutics
4D Molecular Therapeutics, founded in 2013, is a leading late-stage biotechnology company headquartered in the United States. The company is on the forefront of advancing genetic medicines, aiming to revolutionize treatment paradigms with its cutting-edge therapeutics. Their slogan, "Powering the Fu...
About Oxurion NV
Oxurion NV is a biopharmaceutical company with the slogan "Advancing Science. Enhancing Vision." Founded in 1991 and headquartered in Leuven, Belgium, Oxurion is focused on developing next-generation standard of care ophthalmic therapies. The company aims to improve and better preserve vision in pat...
We will tell you when either one moves
BounceWatch watches 4D Molecular Therapeutics and Oxurion NV for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at 4D Molecular Therapeut... and Oxurion NV — by email.
Frequently Asked Questions
Compare 4D Molecular Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at 4D Molecular Therapeutics on 15 Jun 2026, and Oxurion NV on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
